It suggests that ES and mitochondrial damage caused by metabolic stress can also activate the cGAS-STING pathway, and targeting the cGAS-STING pathway has therapeutic potential for the treatment of metabolic diseases (Chung et al., 2019). The gene discussed is STING1; the disease is metabolic disease.